Release Date: 19/02/13 16:44 Summary: Interim Financial Report December 2012 Price Sensitive: No Download Document 293.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%